IOVANCE BIOTHERAPEUTICS INC's ticker is IOVA and the CUSIP is 462260100. A total of 278 filers reported holding IOVANCE BIOTHERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $3,732,000 | -13.2% | 389,588 | 0.0% | 0.66% | -33.3% |
Q2 2022 | $4,301,000 | -33.7% | 389,588 | 0.0% | 0.98% | -35.9% |
Q1 2022 | $6,487,000 | -12.8% | 389,588 | 0.0% | 1.53% | -37.4% |
Q4 2021 | $7,437,000 | -22.6% | 389,588 | 0.0% | 2.45% | -29.8% |
Q3 2021 | $9,607,000 | -27.0% | 389,588 | -23.0% | 3.49% | -35.4% |
Q2 2021 | $13,163,000 | -26.5% | 505,890 | -10.6% | 5.41% | -28.3% |
Q1 2021 | $17,916,000 | -31.8% | 565,890 | 0.0% | 7.55% | -19.6% |
Q4 2020 | $26,257,000 | +33.6% | 565,890 | -5.2% | 9.39% | +12.8% |
Q3 2020 | $19,650,000 | +18.5% | 596,890 | -1.2% | 8.32% | +12.6% |
Q2 2020 | $16,577,000 | +12.7% | 603,890 | +22.9% | 7.39% | -17.1% |
Q1 2020 | $14,710,000 | +17.1% | 491,390 | +8.3% | 8.92% | +17.2% |
Q4 2019 | $12,564,000 | – | 453,890 | – | 7.62% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Fairmount Funds Management LLC | 565,890 | $26,257,000 | 9.39% |
Consonance Capital Management LP | 1,710,803 | $79,381,000 | 7.41% |
GREAT POINT PARTNERS LLC | 917,427 | $42,569,000 | 6.91% |
Avoro Capital Advisors LLC | 7,500,000 | $348,000,000 | 5.99% |
Ghost Tree Capital, LLC | 500,000 | $23,200,000 | 5.17% |
FRAZIER MANAGEMENT LLC | 1,312,999 | $60,923,000 | 4.69% |
Perceptive Advisors | 9,166,304 | $425,316,000 | 4.56% |
Ally Bridge Group (NY) LLC | 360,000 | $16,704,000 | 2.86% |
Orbimed Advisors | 6,645,100 | $308,333,000 | 2.70% |
ACUTA CAPITAL PARTNERS, LLC | 164,800 | $7,647,000 | 2.08% |